U.S. Markets open in 8 hrs 18 mins

AVXL Jul 2021 16.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.44000.0000 (0.00%)
As of 2:39PM EDT. Market open.
Full screen
Previous Close0.4400
Open0.4400
Bid0.2500
Ask0.5500
Strike16.00
Expire Date2021-07-16
Day's Range0.4400 - 0.4400
Contract RangeN/A
Volume4
Open Interest107
  • Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering
    GlobeNewswire

    Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering

    NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced the closing of its previously announced registered direct offering to Deep Track Capital for the is

  • Biotech Stock Roundup: BIIB's AD Drug Update, CVAC's Decline on Vaccine Data & More
    Zacks

    Biotech Stock Roundup: BIIB's AD Drug Update, CVAC's Decline on Vaccine Data & More

    The biotech sector was in focus last week with pipeline updates from Biogen (BIIB) and CureVac (CVAC), among others.

  • Anavex Life Sciences Announces $50 Million Registered Direct Offering
    GlobeNewswire

    Anavex Life Sciences Announces $50 Million Registered Direct Offering

    NEW YORK, June 22, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced that it has entered into a definitive purchase agreement with Deep Track Capital for the issuance a